These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15777236)

  • 1. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
    Marcinkiewicz C
    Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-RGD-containing snake venom disintegrins, functional and structural relations.
    Walsh EM; Marcinkiewicz C
    Toxicon; 2011 Sep; 58(4):355-62. PubMed ID: 21801741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Snake venom disintegrins: classification and therapeutic potential].
    Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
    Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function correlations of snake venom disintegrins.
    Calvete JJ
    Curr Pharm Des; 2005; 11(7):829-35. PubMed ID: 15777237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
    Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
    Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
    Schönthal AH; Swenson SD; Chen TC; Markland FS
    Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Snake Venom's Disintegrins and C-Type Lectins to Anti-Platelet Drugs.
    Lazarovici P; Marcinkiewicz C; Lelkes PI
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31137917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disintegrins.
    McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
    Kuo YJ; Chung CH; Huang TF
    Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of snake venom components to modulate integrin activities in cell-matrix interactions.
    Marcinkiewicz C
    Int J Biochem Cell Biol; 2013 Sep; 45(9):1974-86. PubMed ID: 23811033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colombistatin: a disintegrin isolated from the venom of the South American snake (Bothrops colombiensis) that effectively inhibits platelet aggregation and SK-Mel-28 cell adhesion.
    Sánchez EE; Rodríguez-Acosta A; Palomar R; Lucena SE; Bashir S; Soto JG; Pérez JC
    Arch Toxicol; 2009 Mar; 83(3):271-9. PubMed ID: 18830584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
    Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
    Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First Snake Venom KTS/Disintegrins-Integrin Interactions Using Bioinformatics Approaches.
    Khamessi O; Ben Mabrouk H; Kamoun S; Hkimi C; Ghedira K; Kharrat R
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snake venoms and the hemostatic system.
    Markland FS
    Toxicon; 1998 Dec; 36(12):1749-800. PubMed ID: 9839663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The continuing saga of snake venom disintegrins.
    Calvete JJ
    Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.
    Calvete JJ; Moreno-Murciano MP; Theakston RD; Kisiel DG; Marcinkiewicz C
    Biochem J; 2003 Jun; 372(Pt 3):725-34. PubMed ID: 12667142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
    Okuda D; Morita T
    J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential use of snake venom components in cancer treatment].
    Vivas D; Inga R; Yarlequé A
    Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.
    Brown MC; Eble JA; Calvete JJ; Marcinkiewicz C
    Biochem J; 2009 Jan; 417(1):95-101. PubMed ID: 18774946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.